County
Franklin County Emergency Medical Services
Franklin County Emergency Medical Services (GA) carries 38 drugs across 165 dose entries in its current published protocol, effective 2026-01-01.
Drugs and doses38
Acetaminophen
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Fever | adult | 1 g | IV | not captured | standing | page 311 |
| Fever | adult | 650 mg | PO | not captured | standing | page 311 |
| Fever | peds | 15 mg/kg | PO | not captured | standing | page 311 |
Adenosine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| SVT | adult | 6 mg | IV | not captured | standing | page 313 |
| SVT | peds | 0.1 mg/kg | IV | not captured | standing | page 313 |
Albuterol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 2.5 mg | NEB | not captured | standing | page 315 |
| Asthma / bronchospasm | peds | 2.5 mg | NEB | not captured | standing | page 315 |
Amiodarone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 300 mg | IV/IO | not captured | standing | page 317 |
| Other | peds | 5 mg/kg | IV/IO | not captured | standing | page 317 |
| Wide-complex tachycardia | adult | 150 mg | IV/IO | not captured | standing | page 317 |
| Wide-complex tachycardia | peds | 5 mg/kg | IV/IO | not captured | standing | page 317 |
Aspirin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| STEMI | adult | 324 mg | PO | not captured | standing | page 319 |
Atropine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Bradycardia | adult | 1 mg | IV/IO | not captured | standing | page 321 |
| Bradycardia | peds | 0.02 mg/kg | IV/IO | not captured | standing | page 321 |
| Organophosphate poisoning | adult | 1–2 mg | IV/IO/IM | not captured | standing | page 321 |
| Organophosphate poisoning | peds | 0.02 mg/kg | IV/IO/IM | not captured | standing | page 321 |
Calcium Chloride
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Beta-blocker / calcium-channel-blocker overdose | peds | 20 mg/kg | IV/IO | not captured | standing | page 323 |
| Hyperkalemia | adult | 1 g | IV/IO | not captured | standing | page 323 |
| Hyperkalemia | peds | 10 mg/kg | IV/IO | not captured | standing | page 323 |
Cefazolin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | >80kg=2G, 40-80kg=1G, <40kg=25mg/kg | IV/IO | not captured | standing | page 325 |
| Other | peds | 25 mg/kg | IV/IO | not captured | standing | page 325 |
| Trauma / hemorrhage | adult | >80kg=2G, 40-80kg=1G, <40kg=25mg/kg | IV/IO | not captured | standing | page 325 |
| Trauma / hemorrhage | peds | 25 mg/kg | IV/IO | not captured | standing | page 325 |
Dextrose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | adult | 50–100 mL | IV/IO | not captured | standing | page 327 |
| Hypoglycemia | peds | 5 mL/kg | IV/IO | not captured | standing | page 327 |
Diazepam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 2.5–5 mg | IV/IO | not captured | standing | page 329 |
| Agitation | adult | 5–10 mg | IM | not captured | standing | page 329 |
| Agitation | peds | 0.1 mg/kg | IV/IO | not captured | standing | page 329 |
| Agitation | peds | 0.2 mg/kg | IM | not captured | standing | page 329 |
| Hyperactive delirium | adult | 2.5–5 mg | IV/IO | not captured | standing | page 329 |
| Hyperactive delirium | adult | 5–10 mg | IM | not captured | standing | page 329 |
| Hyperactive delirium | peds | 0.1 mg/kg | IV/IO | not captured | standing | page 329 |
| Hyperactive delirium | peds | 0.2 mg/kg | IM | not captured | standing | page 329 |
| Seizure | adult | 2.5–5 mg | IV/IO | not captured | standing | page 329 |
| Seizure | adult | 5–10 mg | IM | not captured | standing | page 329 |
| Seizure | peds | 0.1 mg/kg | IV/IO | not captured | standing | page 329 |
| Seizure | peds | 0.2 mg/kg | IM | not captured | standing | page 329 |
Diltiazem
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Atrial fibrillation with RVR | adult | 0.25 mg/kg | IV | not captured | standing | page 331 |
| Other | adult | 0.25 mg/kg | IV | not captured | standing | page 331 |
| SVT | adult | 0.25 mg/kg | IV | not captured | standing | page 331 |
Diphenhydramine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Allergic reaction | adult | 25–50 mg | IV/IO/IM | not captured | standing | page 333 |
| Allergic reaction | peds | 1 mg/kg | IV/IO/IM | not captured | standing | page 333 |
| Anaphylaxis | adult | 25–50 mg | IV/IO/IM | not captured | standing | page 333 |
| Anaphylaxis | peds | 1 mg/kg | IV/IO/IM | not captured | standing | page 333 |
| Dystonic reaction | adult | 25–50 mg | IV/IO/IM | not captured | standing | page 333 |
| Dystonic reaction | peds | 1 mg/kg | IV/IO/IM | not captured | standing | page 333 |
Dopamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Bradycardia | adult | 2–20 mcg/kg | IV | not captured | standing | page 335 |
| Bradycardia | peds | 2–20 mcg/kg | IV | not captured | standing | page 335 |
| Cardiogenic shock | adult | 2–20 mcg/kg | IV | not captured | standing | page 335 |
| Cardiogenic shock | peds | 2–20 mcg/kg | IV | not captured | standing | page 335 |
| Hypotension / shock | adult | 2–20 mcg/kg | IV | not captured | standing | page 335 |
| Hypotension / shock | peds | 2–20 mcg/kg | IV | not captured | standing | page 335 |
Epinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 0.3–0.5 mg | IM | not captured | standing | page 337 |
| Anaphylaxis | peds | 0.01 mg/kg | IM | not captured | standing | page 337 |
| Asthma / bronchospasm | adult | 0.3–0.5 mg | IM | not captured | standing | page 337 |
| Asthma / bronchospasm | peds | 0.01 mg/kg | IM | not captured | standing | page 337 |
| Bradycardia | adult | 2–10 mcg | IV | not captured | standing | page 337 |
| Bradycardia | peds | 0.01 mg/kg | IV/IO | not captured | standing | page 338 |
| Cardiac arrest | adult | 1 mg | IV/IO | not captured | standing | page 337 |
| Cardiac arrest | peds | 0.01 mg/kg | IV/IO | not captured | standing | page 337 |
| Croup | peds | 3 mg | NEB | not captured | standing | page 338 |
Etomidate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Procedural sedation | adult | 0.3 mg/kg | IV/IO | not captured | standing | page 65 |
| Procedural sedation | peds | 0.3 mg/kg | IV/IO | not captured | standing | page 65 |
Fentanyl
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 25–100 mcg | IV/IO/IM/IN | not captured | standing | page 85 |
| Mild to moderate pain | peds | 1 mcg/kg | IV/IO/IM/IN | not captured | standing | page 85 |
| RSI induction | adult | 1–3 mcg/kg | IV/IO | not captured | standing | page 65 |
| RSI induction | peds | 1–2 mcg/kg | IV/IO | not captured | standing | page 65 |
Furosemide
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| CHF / pulmonary edema | adult | 40 mg | IV/IO | not captured | standing | page 344 |
| CHF / pulmonary edema | adult | 40 mg | IV/IO | not captured | standing | page 344 |
| CHF / pulmonary edema | peds | 1–2 mg/kg | IV/IO | not captured | standing | page 344 |
| CHF / pulmonary edema | peds | 1–2 mg/kg | IV/IO | not captured | standing | page 344 |
Glucagon
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Beta-blocker / calcium-channel-blocker overdose | adult | 4 mg | IV/IO | not captured | standing | page 118 |
| Beta-blocker / calcium-channel-blocker overdose | peds | 0.1 mg/kg | IV/IO | not captured | standing | page 118 |
| Hypoglycemia | adult | 1 mg | IM/SQ | not captured | standing | page 94 |
| Hypoglycemia | peds | 0.1 mg/kg | IM/SQ | not captured | standing | page 94 |
Heparin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| STEMI | adult | 60 unit/kg | IV | not captured | standing | page 153 |
Ipratropium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 0.5 mg | NEB | not captured | standing | page 168 |
| Asthma / bronchospasm | peds | 0.5 mg | NEB | not captured | standing | page 168 |
Ketamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hyperactive delirium | adult | 4 mg/kg | IM | not captured | standing | page 103 |
| Hyperactive delirium | peds | 4 mg/kg | IM | not captured | standing | page 103 |
| Mild to moderate pain | adult | 0.25 mg/kg | IV/IO | not captured | standing | page 128 |
| Mild to moderate pain | adult | 0.5 mg/kg | IM/IN | not captured | standing | page 128 |
| Mild to moderate pain | peds | 0.25 mg/kg | IV/IO | not captured | standing | page 128 |
| Mild to moderate pain | peds | 0.5 mg/kg | IM/IN | not captured | standing | page 128 |
| Procedural sedation | adult | 1 mg/kg | IV/IO | not captured | standing | page 355 |
| RSI induction | adult | 1–2 mg/kg | IV/IO | not captured | standing | page 65 |
| RSI induction | peds | 1–2 mg/kg | IV/IO | not captured | standing | page 65 |
Ketorolac
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 15 mg | IV | not captured | standing | page 225 |
| Mild to moderate pain | adult | 30 mg | IM | not captured | standing | page 225 |
| Mild to moderate pain | peds | 0.5 mg/kg | IV | not captured | standing | page 225 |
| Mild to moderate pain | peds | 0.5 mg/kg | IM | not captured | standing | page 225 |
Labetalol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Eclampsia / pre-eclampsia | adult | 20 mg | IV | not captured | standing | page 213 |
| Other | adult | 10 mg | IV | not captured | standing | page 192 |
Lidocaine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1–1.5 mg/kg | IV/IO | not captured | standing | page 362 |
| Other | peds | 1 mg/kg | IV/IO | not captured | standing | page 362 |
| Wide-complex tachycardia | adult | 1–1.5 mg/kg | IV/IO | not captured | standing | page 362 |
| Wide-complex tachycardia | peds | 1 mg/kg | IV/IO | not captured | standing | page 362 |
| VF / pulseless VT | adult | 1–1.5 mg/kg | IV/IO | not captured | standing | page 362 |
| VF / pulseless VT | peds | 1 mg/kg | IV/IO | not captured | standing | page 362 |
Magnesium Sulfate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 2 g | IV/IO | not captured | standing | page 364 |
| Asthma / bronchospasm | peds | 25–50 mg/kg | IV/IO | not captured | standing | page 364 |
| Eclampsia / pre-eclampsia | adult | 4 g | IV/IO | not captured | standing | page 213 |
| Other | adult | 2 g | IV/IO | not captured | standing | page 364 |
| Other | peds | 25–50 mg/kg | IV/IO | not captured | standing | page 364 |
| VF / pulseless VT | adult | 2 g | IV/IO | not captured | standing | page 364 |
| VF / pulseless VT | peds | 50 mg/kg | IV/IO | not captured | standing | page 364 |
Methylprednisolone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 125 mg | IV/IO/IM | not captured | standing | page 366 |
| Anaphylaxis | peds | 2 mg/kg | IV/IO/IM | not captured | standing | page 366 |
| Other | adult | 125 mg | IV/IO/IM | not captured | standing | page 366 |
| Other | peds | 2 mg/kg | IV/IO/IM | not captured | standing | page 366 |
| Respiratory distress | adult | 125 mg | IV/IO/IM | not captured | standing | page 366 |
| Respiratory distress | peds | 2 mg/kg | IV/IO/IM | not captured | standing | page 366 |
Metoprolol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Atrial fibrillation with RVR | adult | 2.5–5 mg | IV/IO | not captured | standing | page 368 |
Midazolam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hyperactive delirium | adult | 2.5–5 mg | IM/IN | not captured | standing | page 370 |
| Hyperactive delirium | peds | 0.1 mg/kg | IV/IO | not captured | standing | page 370 |
| Hyperactive delirium | peds | 0.2 mg/kg | IM/IN | not captured | standing | page 370 |
| Seizure | adult | 2.5–5 mg | IM/IN | not captured | standing | page 370 |
| Seizure | peds | 0.1 mg/kg | IV/IO | not captured | standing | page 370 |
| Seizure | peds | 0.2 mg/kg | IM/IN | not captured | standing | page 370 |
Morphine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Burns | adult | 2–4 mg | IV/IM | not captured | standing | page 109 |
| Burns | peds | 0.1 mg/kg | IV/IM | not captured | standing | page 109 |
| Other | adult | 2–4 mg | IV/IM | not captured | standing | page 106 |
| Other | peds | 0.1 mg/kg | IV/IM | not captured | standing | page 106 |
| Mild to moderate pain | adult | 2–4 mg | IV/IM | not captured | standing | page 85 |
| Mild to moderate pain | adult | 2–4 mg | IV/IO/IM | not captured | standing | page 225 |
| Mild to moderate pain | peds | 0.1 mg/kg | IV/IM | not captured | standing | page 85 |
| Mild to moderate pain | peds | 0.1 mg/kg | IV/IO/IM | not captured | standing | page 225 |
Naloxone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 0.4–2 mg | IV/IM/IN | not captured | standing | page 94 |
| Other | adult | 0.4–2 mg | IV/IO/IM/IN | not captured | standing | page 220 |
| Other | peds | 0.1 mg/kg | IV/IM/IN | not captured | standing | page 94 |
| Other | peds | 0.1 mg/kg | IV/IO/IM/IN | not captured | standing | page 220 |
Nitroglycerin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 0.4 mg | SL | not captured | standing | page 153 |
| Other | adult | 0.4 mg | SL | not captured | standing | page 192 |
| Respiratory distress | adult | 0.4 mg | SL | not captured | standing | page 235 |
Norepinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cardiac arrest | adult | 8–12 mcg | IV | not captured | standing | page 133 |
| Cardiac arrest | peds | 0.05–2 mcg/kg | IV | not captured | standing | page 133 |
| Hypotension / shock | adult | 3–30 mcg | IV | not captured | standing | page 249 |
| Hypotension / shock | peds | 0.05–2 mcg/kg | IV | not captured | standing | page 249 |
| Post-ROSC care | peds | 0.05–2 mcg/kg | IV | not captured | standing | page 142 |
| Respiratory distress | adult | 8–12 mcg | IV | not captured | standing | page 235 |
Ondansetron
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 4 mg | IV/IM/IN | not captured | standing | page 202 |
| Nausea / vomiting | peds | 0.1 mg/kg | IV/IM/IN | not captured | standing | page 202 |
| Other | adult | 4 mg | IV | not captured | standing | page 172 |
| Other | peds | 0.1 mg/kg | IV | not captured | standing | page 172 |
| Mild to moderate pain | adult | 4 mg | IV/IM | not captured | standing | page 85 |
| Mild to moderate pain | peds | 0.1 mg/kg | IV/IM | not captured | standing | page 85 |
Oral Glucose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | adult | 15 g | PO | not captured | standing | page 382 |
| Hypoglycemia | peds | 7.5 g | PO | not captured | standing | page 382 |
Sodium Bicarbonate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 1 mEq/kg | IV | not captured | standing | page 103 |
| Cardiac arrest | peds | 1 mEq/kg | IV | not captured | standing | page 133 |
| Crush injury | adult | 1 mEq/kg | IV | not captured | standing | page 156 |
| Crush injury | peds | 1 mEq/kg | IV | not captured | standing | page 156 |
| Hyperkalemia | adult | 1 mEq/kg | IV | not captured | standing | page 190 |
| Hyperkalemia | peds | 1 mEq/kg | IV | not captured | standing | page 190 |
| Other | adult | 1 mEq/kg | IV | not captured | standing | page 220 |
| Other | peds | 1 mEq/kg | IV | not captured | standing | page 220 |
Thiamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | adult | 100 mg | IV/IO | not captured | standing | page 388 |
| Hypoglycemia | peds | 2 mg/kg | IV/IO | not captured | standing | page 388 |
Ticagrelor
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| STEMI | adult | 180 mg | PO | not captured | standing | page 154 |
Tranexamic Acid
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Head injury / TBI | adult | 2 g | IV/IO | not captured | standing | page 283 |
| Head injury / TBI | peds | 15 mg/kg | IV/IO | not captured | standing | page 283 |
| Trauma / hemorrhage | adult | 2 g | IV/IO | not captured | standing | page 271 |
| Trauma / hemorrhage | adult | 2 g | IV/IO | not captured | standing | page 392 |
| Trauma / hemorrhage | peds | 15 mg/kg | IV/IO | not captured | standing | page 271 |
| Trauma / hemorrhage | peds | 15 mg/kg | IV/IO | not captured | standing | page 392 |